Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Summit Therapeutics (SMMT) Other Operating Expenses: 2015-2024

Historic Other Operating Expenses for Summit Therapeutics (SMMT) over the last 7 years, with Dec 2024 value amounting to $313,000.

  • Summit Therapeutics' Other Operating Expenses rose 14.53% to $205,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $15.1 million, marking a year-over-year increase of 114.90%. This contributed to the annual value of $313,000 for FY2024, which is 68.73% down from last year.
  • Per Summit Therapeutics' latest filing, its Other Operating Expenses stood at $313,000 for FY2024, which was down 68.73% from $1.0 million recorded in FY2023.
  • Summit Therapeutics' 5-year Other Operating Expenses high stood at $14.4 million for FY2022, and its period low was $313,000 during FY2024.
  • For the 3-year period, Summit Therapeutics' Other Operating Expenses averaged around $5.2 million, with its median value being $1.0 million (2023).
  • Per our database at Business Quant, Summit Therapeutics' Other Operating Expenses spiked by 6,035.71% in 2020 and then plummeted by 93.06% in 2023.
  • Yearly analysis of 4 years shows Summit Therapeutics' Other Operating Expenses stood at $859,000 in 2020, then reached $14.4 million in 2022, then tumbled by 93.06% to $1.0 million in 2023, then tumbled by 68.73% to $313,000 in 2024.